Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Rising Tide Foundation | OTHER |
Not provided
Not provided
Not provided
The goal of this stepped-wedge randomized controlled trial is to investigate whether implementation of a best practice program for preoperative optimisation (prehabilitation program) with a focus on screening, assessment, and intervention of 8 potentially (partly) modifiable risk factors in patients with (suspected) pancreatic cancer will improve outcome. The main questions it will aim to answer are:
Background In the past, little attention has been given in the daily practice to the patient's condition before an operation. Recent studies have shown the benefit of preoperative optimisation programs. However, these studies consisted only of smaller studies and were mainly performed in patients who underwent colorectal surgery. Although promising, unfortunately, strong evidence to support the contribution of prehabilitation to optimize the functional outcome after surgery is still lacking and consequently it is not included in the Dutch basic health insurance package.
Objective To investigate whether implementation of a best practice program for preoperative optimisation of patients with a focus on screening, assessment, and intervention of 8 potentially (partly) modifiable risk factors (low (aerobic) fitness level, malnutrition, low psychological resilience, comorbidities (iron deficiency (anaemia), impaired glucose control and frailty), and intoxications (alcohol and smoking behaviour)) will improve the time to functional recovery.
Study design A nationwide stepped-wedge cluster randomized trial. In this design all participating centres will cross over from current practice to the best practice program, in a randomised order. At the end of the study, all centres will have implemented the best practice program.
Study population 13 centres performing major pancreatic surgery in the Netherlands collaborating within the Dutch Pancreatic Cancer Group (DPCG).
Intervention Preoperative screening of all patients scheduled for pancreatic resection on (aerobic) fitness level, malnutrition risk, psychological resilience, haemoglobin, iron and HbA1c concentration, frailty, and alcohol and smoking behaviour. All patients are provided with a patient-tailored, multimodal prehabilitation program, in which these potentially (partly) modifiable factors are preoperatively addressed. This program is based on findings in previous screening and prehabilitation programs, a national inventory of current preoperative care protocols and expert opinion. Consensus upon this program was reached with pancreatic surgeons from all centres of the DPCG. The final program was critically reviewed by the advisory committee of internationally respected experts in the field of prehabilitation and pancreatology.
Comparison Preoperative care according to current practice.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Standard care | No Intervention | Receiving standard preoperative care | |
| Best practice program | Experimental | Implementation of best practice preoperative optimisation program |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Preoperative optimisation program | Behavioral | Preoperative screening of all patients scheduled for pancreatic resection on (aerobic) fitness level, malnutrition risk, psychological resilience, haemoglobin, iron and HbA1c concentration, frailty, and alcohol and smoking behaviour. All patients are provided with a patient-tailored, multimodal prehabilitation program, in which these potentially (partly) modifiable factors are preoperatively addressed |
| Measure | Description | Time Frame |
|---|---|---|
| Time to functional recovery | Functional recovery is achieved when all of the following five criteria are met: a) restored level of mobility at the preoperative level, b) sufficient pain control with oral medication alone, c) ability to maintain at least 50% daily required energy intake, d) no intravenous fluid administration, and e) no clinical signs of infection. | On average 6-10 days |
| Measure | Description | Time Frame |
|---|---|---|
| Comprehensive Complication Index (CCI) | The CCI is calculated as the sum of all complications that are weighted for their severity, with a range from 0 to 100, whereby a higher score indicates presence of more complications and/or more severe complications. | 30 days postoperative |
| Length of hospital stay |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Marcel den Dulk, MD PhD | Contact | +3143 3875492 | marcel.den.dulk@mumc.nl | |
| Heleen Driessens, MD | Contact | +316 83058108 | h.driessens@umcg.nl |
| Name | Affiliation | Role |
|---|---|---|
| Marcel den Dulk, MD PhD | Maastricht University Medical Center/ University Maastricht | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Jeroen Bosch Hospital | Recruiting | 's-Hertogenbosch | Netherlands |
All of the individual participant data collected during the trial will be shared, after deidentification upon reasonable request.
Beginning 3 months and ending 5 years following article publication
Data will be available upon request. Request should be directed to marcel.den.dulk@mumc.nl.
Not provided
Not provided
Stepped-wedge cluster randomized superiority trial
Not provided
Not provided
Not provided
Not provided
|
Length of hospital stay of the primary admission, measured in days |
| On average 2 weeks postoperative |
| Readmissions | Readmissions within 30 days after discharge | 30 days after discharge of primary admission |
| Postoperative complications | Any postoperative complication | During primary admission, on average 14 weeks postoperative |
| Incremental cost-effectiveness ratio (ICER) | The difference in costs between standard care and best practice care divided by the difference in health benefits, measured in quality-adjusted life years (QALYs). | 1 year postoperative |
| Evaluation of health status | Reported health status measured with questionnaire EQ-5D-5L | At baseline, 3 months and 12 months postoperative |
| Evaluation of quality of life for cancer patients | Reported quality of life measured with questionnaire EORTC QLQ-C30 | At baseline, 3 months and 12 months postoperative |
| Amsterdam University Medical Center | Recruiting | Amsterdam | Netherlands |
|
| OLVG | Recruiting | Amsterdam | Netherlands |
|
| Amphia Hospital | Recruiting | Breda | Netherlands |
|
| Catharina Hospital | Recruiting | Eindhoven | Netherlands |
|
| Medisch Spectrum Twente | Recruiting | Enschede | Netherlands |
|
| University Medical Center Groningen | Recruiting | Groningen | Netherlands |
|
| Medisch Centrum Leeuwarden | Recruiting | Leeuwarden | Netherlands |
|
| Leiden University Medical Center | Recruiting | Leiden | Netherlands |
|
| Maatricht University Medical Center | Recruiting | Maastricht | 6202AZ | Netherlands |
|
| Radboud University Medical Center | Recruiting | Nijmegen | Netherlands |
|
| Erasmus Medical Center | Recruiting | Rotterdam | Netherlands |
|
| RAKU | Recruiting | Utrecht | Netherlands |
|
| ID | Term |
|---|---|
| D010190 | Pancreatic Neoplasms |
| D011183 | Postoperative Complications |
| ID | Term |
|---|---|
| D004067 | Digestive System Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D004701 | Endocrine Gland Neoplasms |
| D004066 | Digestive System Diseases |
| D010182 | Pancreatic Diseases |
| D004700 | Endocrine System Diseases |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided